These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 25273568

  • 1. Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using T1-weighted and T2-weighted cardiovascular magnetic resonance.
    Jordan JH, D'Agostino RB, Hamilton CA, Vasu S, Hall ME, Kitzman DW, Thohan V, Lawrence JA, Ellis LR, Lash TL, Hundley WG.
    Circ Cardiovasc Imaging; 2014 Nov; 7(6):872-9. PubMed ID: 25273568
    [Abstract] [Full Text] [Related]

  • 2. Frequency of Left Ventricular End-Diastolic Volume-Mediated Declines in Ejection Fraction in Patients Receiving Potentially Cardiotoxic Cancer Treatment.
    Meléndez GC, Sukpraphrute B, D'Agostino RB, Jordan JH, Klepin HD, Ellis L, Lamar Z, Vasu S, Lesser G, Burke GL, Weaver KE, Ntim WO, Hundley WG.
    Am J Cardiol; 2017 May 15; 119(10):1637-1642. PubMed ID: 28341361
    [Abstract] [Full Text] [Related]

  • 3. Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors.
    Jordan JH, Vasu S, Morgan TM, D'Agostino RB, Meléndez GC, Hamilton CA, Arai AE, Liu S, Liu CY, Lima JA, Bluemke DA, Burke GL, Hundley WG.
    Circ Cardiovasc Imaging; 2016 Aug 15; 9(8):. PubMed ID: 27502058
    [Abstract] [Full Text] [Related]

  • 4. Early Detection of Anthracycline-Induced Cardiotoxicity in Breast Cancer Survivors With T2 Cardiac Magnetic Resonance.
    Lustberg MB, Reinbolt R, Addison D, Ruppert AS, Moore S, Carothers S, Suresh A, Das H, Berger M, Ramaswamy B, Wesolowski R, Binkley P, Raman SV, Shapiro CL.
    Circ Cardiovasc Imaging; 2019 May 15; 12(5):e008777. PubMed ID: 31060375
    [No Abstract] [Full Text] [Related]

  • 5. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
    Stoodley PW, Richards DA, Boyd A, Hui R, Harnett PR, Meikle SR, Byth K, Stuart K, Clarke JL, Thomas L.
    Eur J Cancer; 2013 Nov 15; 49(16):3396-403. PubMed ID: 23937961
    [Abstract] [Full Text] [Related]

  • 6. Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease.
    Ferreira de Souza T, Quinaglia A C Silva T, Osorio Costa F, Shah R, Neilan TG, Velloso L, Nadruz W, Brenelli F, Sposito AC, Matos-Souza JR, Cendes F, Coelho OR, Jerosch-Herold M, Coelho-Filho OR.
    JACC Cardiovasc Imaging; 2018 Aug 15; 11(8):1045-1055. PubMed ID: 30092965
    [Abstract] [Full Text] [Related]

  • 7. Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines.
    Barbosa MF, Fusco DR, Gaiolla RD, Werys K, Tanni SE, Fernandes RA, Ribeiro SM, Szarf G.
    BMC Cardiovasc Disord; 2021 Apr 12; 21(1):170. PubMed ID: 33845778
    [Abstract] [Full Text] [Related]

  • 8. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.
    Drafts BC, Twomley KM, D'Agostino R, Lawrence J, Avis N, Ellis LR, Thohan V, Jordan J, Melin SA, Torti FM, Little WC, Hamilton CA, Hundley WG.
    JACC Cardiovasc Imaging; 2013 Aug 12; 6(8):877-85. PubMed ID: 23643285
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular magnetic resonance characterization of myocardial tissue injury in a miniature swine model of cancer therapy-related cardiovascular toxicity.
    Nakata K, Kucukseymen S, Cai X, Yankama T, Rodriguez J, Sai E, Pierce P, Ngo L, Nakamori S, Tung N, Manning WJ, Nezafat R.
    J Cardiovasc Magn Reson; 2024 Aug 12; 26(1):101033. PubMed ID: 38460840
    [Abstract] [Full Text] [Related]

  • 10. Simultaneous Left Ventricular Volume and Strain Changes During Chemotherapy Associate With 2-Year Postchemotherapy Measures of Left Ventricular Ejection Fraction.
    Suerken CK, D'Agostino RB, Jordan JH, Meléndez GC, Vasu S, Lamar ZS, Hundley WG.
    J Am Heart Assoc; 2020 Jan 21; 9(2):e015400. PubMed ID: 31959033
    [Abstract] [Full Text] [Related]

  • 11. Echocardiographic Assessment of Cardiotoxic Effects of Cancer Therapy.
    Bottinor WJ, Migliore CK, Lenneman CA, Stoddard MF.
    Curr Cardiol Rep; 2016 Oct 21; 18(10):99. PubMed ID: 27566332
    [Abstract] [Full Text] [Related]

  • 12. Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab.
    Tan TC, Bouras S, Sawaya H, Sebag IA, Cohen V, Picard MH, Passeri J, Kuter I, Scherrer-Crosbie M.
    J Am Soc Echocardiogr; 2015 May 21; 28(5):509-14. PubMed ID: 25772019
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular magnetic resonance parametric techniques to characterize myocardial effects of anthracycline therapy in adults with normal left ventricular ejection fraction: a systematic review and meta-analysis.
    Musella F, Librera M, Sibilio G, Boccalatte M, Tagliamonte G, Cavaglià E, Ferrara I, Puglia M, Dell'Aversana S, Ducci CB, Dellegrottaglie S, Savarese G, Scatteia A.
    Curr Probl Cardiol; 2024 Jul 21; 49(7):102609. PubMed ID: 38697332
    [Abstract] [Full Text] [Related]

  • 14. Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta-Analysis of Placebo Arms From Randomized Controlled Trials.
    Jeyaprakash P, Sangha S, Ellenberger K, Sivapathan S, Pathan F, Negishi K.
    J Am Heart Assoc; 2021 Mar 16; 10(6):e018802. PubMed ID: 33660514
    [Abstract] [Full Text] [Related]

  • 15. Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy.
    Jolly MP, Jordan JH, Meléndez GC, McNeal GR, D'Agostino RB, Hundley WG.
    J Cardiovasc Magn Reson; 2017 Aug 02; 19(1):59. PubMed ID: 28768517
    [Abstract] [Full Text] [Related]

  • 16. Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective observational study.
    Barthur A, Brezden-Masley C, Connelly KA, Dhir V, Chan KK, Haq R, Kirpalani A, Barfett JJ, Jimenez-Juan L, Karur GR, Deva DP, Yan AT.
    J Cardiovasc Magn Reson; 2017 Apr 10; 19(1):44. PubMed ID: 28395671
    [Abstract] [Full Text] [Related]

  • 17. Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity.
    Henriksen PA, Hall P, Oikonomidou O, MacPherson IR, Maclean M, Lewis S, McVicars H, Broom A, Scott F, McKay P, Borley A, Rowntree C, Lord S, Collins G, Radford J, Guppy A, Payne JR, Newby DE, Mills NL, Lang NN.
    Circ Heart Fail; 2022 Jul 10; 15(7):e009445. PubMed ID: 35766037
    [Abstract] [Full Text] [Related]

  • 18. Left atrial reservoir longitudinal strain and its incremental value to the left ventricular global longitudinal strain in predicting anthracycline-induced cardiotoxicity.
    Li Z, Zhao R, Zhang Q, Shen Y, Shu X, Cheng L.
    Echocardiography; 2024 Apr 10; 41(4):e15805. PubMed ID: 38558436
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the Changes in Cardiac Structure and Function in Mice Treated With Anthracyclines Using Serial Cardiac Magnetic Resonance Imaging.
    Farhad H, Staziaki PV, Addison D, Coelho-Filho OR, Shah RV, Mitchell RN, Szilveszter B, Abbasi SA, Kwong RY, Scherrer-Crosbie M, Hoffmann U, Jerosch-Herold M, Neilan TG.
    Circ Cardiovasc Imaging; 2016 Dec 10; 9(12):. PubMed ID: 27923796
    [Abstract] [Full Text] [Related]

  • 20. Abnormal Myocardial Strain Indices in Children Receiving Anthracycline Chemotherapy.
    Pignatelli RH, Ghazi P, Reddy SC, Thompson P, Cui Q, Castro J, Okcu MF, Jefferies JL.
    Pediatr Cardiol; 2015 Dec 10; 36(8):1610-6. PubMed ID: 26049414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.